The data showed that kids who don’t see their BMI decline between ages 1 and 6 have a greater risk of obesity. This risk was ...

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...

The researchers assessed prenatal exposures to smoking, alcohol, and stress (depression or anxiety) as well as maternal ...

NAIROBI, Kenya — In many African cultures, a big belly has long been seen as a sign of wealth. But this perception is proving ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

HHS Secretary Robert F. Kennedy Jr. threatened to bar NIH scientists from publishing in leading medical journals, saying the ...

Not all children grow the same way. A new study from the Environmental influences on Child Health Outcomes (ECHO) Program ...

As of late 2024, only 14 state Medicaid programs cover GLP-1 drugs like Wegovy, Saxenda, or Zepbound for the treatment of obesity. These states are: California, Connecticut, Indiana, Maryland, ...

Patients taking Eli Lilly’s drug to combat obesity, Zepbound, lost more weight than those who took Novo Nordisk’s Wegovy in a ...

The 70-page report from the Make America Healthy Again Commission targets the pharmaceutical and food industries for growing rates of childhood chronic disease.

Those aged 10-24 are confronting rising rates of chronic diseases, mental disorders and obesity, say experts calling for ...

The highly anticipated White House report on childhood diseases, titled "Make Our Children Healthy Again: Assessment," was ...